What does a serum creatinine of 1.38 mg/dL indicate and how should it be managed?

A serum creatinine of 1.38 mg/dL requires immediate calculation of estimated GFR (eGFR) using the CKD-EPI equation to determine if chronic kidney disease is present and assess cardiovascular risk.

Clinical Significance

Serum creatinine of 1.38 mg/dL may represent normal kidney function or mild-to-moderate renal impairment depending on age, sex, race, and body composition. The absolute creatinine value alone is insufficient for clinical decision-making 1, 2. This value could correspond to an eGFR ranging from normal (>90 mL/min/1.73 m²) in a young, muscular male to Stage 3 CKD (<60 mL/min/1.73 m²) in an elderly female with low muscle mass 3, 1.

Key Contextual Factors

Creatinine levels are influenced by:

• Muscle mass: Reduced in elderly, females, malnutrition, chronic illness 1, 4
• Age: Creatinine decreases with age despite declining GFR 1
• Sex: Women have 15-20% lower values than men 1
• Race: Black individuals have higher muscle mass and creatinine 2
• Diet: High protein intake increases creatinine 4

Critical pitfall: A "normal" creatinine (0.6-1.3 mg/dL) can mask significant renal impairment—up to 40% GFR loss may occur before creatinine rises above normal range 1, 5.

Immediate Management Algorithm

Step 1: Calculate eGFR

Use the CKD-EPI equation (preferred over MDRD) 2:

• Requires: age, sex, race, serum creatinine
• More accurate, especially at GFR ≥60 mL/min/1.73 m²
• Available at online calculators

Interpretation by eGFR category 2:

• ≥90: Normal (G1) - if no other kidney damage markers
• 60-89: Mild reduction (G2) - requires albuminuria for CKD diagnosis
• 45-59: Moderate reduction (G3a) - CKD Stage 3a
• 30-44: Moderate reduction (G3b) - CKD Stage 3b
• <30: Severe reduction (G4-5) - requires nephrology referral

Step 2: Assess for Albuminuria

Obtain spot urine albumin-to-creatinine ratio (ACR) 3, 2:

• <30 mg/g: Normal (A1)
• 30-300 mg/g: Moderately increased (A2) - "microalbuminuria"
• >300 mg/g: Severely increased (A3) - "macroalbuminuria"

This is essential because:

• Albuminuria predicts cardiovascular events and CKD progression 3, 6
• eGFR 45-59 with normal ACR may not represent true CKD 2
• One-fifth of patients with normal creatinine have renal insufficiency when properly assessed 1

Step 3: Confirmatory Testing (if eGFR 45-59 and ACR <30)

Consider serum cystatin C 2:

• Not affected by muscle mass, age, or sex
• Use cystatin C-based eGFR to confirm CKD
• Two-thirds of patients with eGFR 45-59 will have confirmed CKD by cystatin C

Step 4: Risk Stratification

Cardiovascular Risk Assessment 7, 8: Even "high-normal" creatinine (within reference range) independently predicts:

• Cardiovascular morbidity and mortality (RR 1.30 per 0.23 mg/dL increase) 7
• Stroke risk (increased above 1.3 mg/dL, even in normotensive patients) 8
• This risk persists after adjusting for blood pressure and left ventricular hypertrophy 7

CKD Staging (if eGFR <60 or albuminuria present) 2:

• Stage G3a + A1: Moderate risk
• Stage G3a + A2: High risk
• Stage G3b + A2: Very high risk
• Any stage + A3: Very high to highest risk

Ongoing Management

If eGFR ≥60 and ACR <30:

• Repeat annually if risk factors present (diabetes, hypertension)
• Address cardiovascular risk factors
• Avoid nephrotoxins (NSAIDs, contrast dye) 9

If eGFR 45-59 (Stage 3a CKD):

• Monitor creatinine and eGFR every 6-12 months
• Optimize blood pressure (<130/80 mmHg target)
• Screen for and treat albuminuria
• Adjust medication dosing per renal function 10
• Consider nephrology referral if progressive decline or complications 6, 11

If eGFR 30-44 (Stage 3b CKD):

• Monitor every 3-6 months
• Nephrology referral recommended 6, 11
• Evaluate for CKD complications (anemia, bone disease, metabolic acidosis)
• Begin preparation for potential renal replacement therapy

If eGFR <30 (Stage 4-5 CKD):

• Urgent nephrology referral required 6, 11
• At least 12 months of nephrology care needed before dialysis 11

Treatment Considerations

For patients with albuminuria 6:

• ACE inhibitors or ARBs are first-line (delay progression)
• Monitor potassium (risk of hyperkalemia)
• Expect creatinine increase up to 20% after starting therapy—this is acceptable and not progressive deterioration 3

Medication dosing 10:

• Use Cockcroft-Gault equation for drug dosing adjustments
• Many medications require dose reduction when eGFR <60

Common pitfall: Do not dismiss a creatinine of 1.38 as "borderline normal" without calculating eGFR and checking for albuminuria—this value may represent significant renal impairment with elevated cardiovascular risk, particularly in elderly patients, women, or those with low muscle mass 1, 7, 8.